Monitoring with mean kinetic temperature in GxP environments
Supplied by Vaisala Oyj on Tuesday, 14 February, 2017
Regulatory bodies in drug manufacturing and distribution have long been working together to create standards for temperature monitoring that will ensure the quality of drugs, devices and biotechnology. The mean kinetic temperature (MKT) value has been identified as a potential tool for evaluating the impact of temperature on product quality.
Download this paper to discover how to perform the calculation and some basic recommendations for its appropriate use.
Related White Papers
Limit your risk, avoid waste and ensure compliance to government legislation
This paper provides an overview of the importance...
Key insights into the diversity of immune cells and signalling pathways
This whitepaper provides you with critical...
Digital innovation drives smarter, faster biologics development
[Case study] From bottleneck to breakthroughs: a...
